|
Reaching new heights . . .
MASS. GENERAL TO BE RENAMED

MGH is sporting a new "up" look following the unprecedented sale of naming rights to Levitra
By Alvin T. Fuller Boston Bureau Chief with Dr. V. B. Batz Medical Editor
BOSTON, Massachusetts – The financial troubles of the Massachusetts General Hospital have been solved through an innovative deal with a leading drug company, MGH officials announced today.
After months of speculation, hospital overseers announced that in exchange for a grant of $250,000,000, the hospital would be co-branded "Levitra Mass. General Hospital."
"We're very excited about the opportunities that this grant will provide," explained hospital chief executive Dr. Woodrow Reamer at a press conference held at the Levitra Continuing Medical Education Center in Las Vegas, Nevada.
"This grant will permit us to erect a state-of-the-art physician training and comfort [Surely, conference? – Ed.] center on the grounds of our existing medical campus in the West End, and when you think of erections, you naturally think of Levitra," Dr. Reamer announced. "Renaming the hospital allows us to meet our financial needs without sacrificing patient care, which of course must be our first priority."
Asked what Levitra manufacturer GlaxoSmithKline would get out of the deal, Dr. Reamer said that associating the erectile dysfunction cure with a world-class medical center would provide a "boost" to the drug, which faces stiff competition from market leader Viagra. "Now when you think of Levitra, you'll think of Mass. General. If that doesn't make your wedango stand up and salute I don't know what will."

MGH supremo Dr. Woodrow Reamer celebrates the big-bucks naming deal with Levitra marketing team
The innovative physician and chief executive said that all hospital signage and stationery would include the "Levitra" name. In addition, he said Levitra would be advertised "tastefully" in all hospital operating and recovery rooms.
Some critics have questioned whether renaming the hospital after a drug in exchange for a whopping fee might call into question the integrity of the institution. "Anyone who thinks the integrity of this great institution can be sold for a mere $250 million is just the kind of limpd*** who could use the strong, reliable erections provided by Levitra. Consult your doctor," snarled Dr. Reamer.
Mass. General insiders say that more naming arrangements may be in the works as the hospital struggles to treat all comers, including lowlifes without any health insurance. The hospital is rumored to be close to a $50 million deal to rename its basement refectory the Nexium Cafeteria and a $10 million rights package for the Preparation H Trustees' Room.
|